BOK Financial Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Sell
8,275
-70
-0.8% -$1.86K 0.01% 171
2025
Q4
$208K Sell
8,345
-450
-5% -$11.3K 0.01% 179
2025
Q3
$224K Hold
8,795
0.01% 167
2025
Q2
$213K Hold
8,795
0.01% 172
2025
Q1
$223K Sell
8,795
-5,071
-37% -$133K 0.02% 165
2024
Q4
$368K Sell
13,866
-706
-5% -$19.1K 0.03% 142
2024
Q3
$422K Buy
14,572
+1,298
+10% +$37.9K 0.03% 141
2024
Q2
$371K Sell
13,274
-558
-4% -$15.4K 0.03% 143
2024
Q1
$384K Buy
13,832
+558
+4% +$15.5K 0.03% 144
2023
Q4
$382K Sell
13,274
-69
-0.5% -$2.09K 0.03% 137
2023
Q3
$443K Buy
13,343
+988
+8% +$34.9K 0.04% 128
2023
Q2
$453K Buy
12,355
+491
+4% +$19.1K 0.04% 128
2023
Q1
$484K Buy
11,864
+31
+0.3% +$1.34K 0.04% 132
2022
Q4
$606K Sell
11,833
-6,131
-34% -$294K 0.05% 121
2022
Q3
$786K Sell
17,964
-472
-3% -$22.9K 0.07% 110
2022
Q2
$967K Sell
18,436
-22,111
-55% -$1.13M 0.09% 107
2022
Q1
$2.1M Sell
40,547
-735
-2% -$38.1K 0.15% 94
2021
Q4
$2.44M Buy
41,282
+14,309
+53% +$709K 0.17% 87
2021
Q3
$1.16M Buy
26,973
+4,246
+19% +$188K 0.09% 103
2021
Q2
$890K Buy
22,727
+3,806
+20% +$148K 0.07% 112
2021
Q1
$686K Sell
18,921
-74
-0.4% -$2.63K 0.06% 113
2020
Q4
$699K Buy
18,995
+2,237
+13% +$82.1K 0.07% 108
2020
Q3
$583K Sell
16,758
-638
-4% -$22.4K 0.06% 111
2020
Q2
$540K Sell
17,396
-911
-5% -$30.9K 0.06% 114
2020
Q1
$567K Sell
18,307
-17,682
-49% -$603K 0.07% 121
2019
Q4
$1.34M Buy
35,989
+21,016
+140% +$749K 0.11% 89
2019
Q3
$510K Sell
14,973
-987
-6% -$35.9K 0.07% 66
2019
Q2
$656K Buy
15,960
+1,281
+9% +$50.9K 0.1% 59
2019
Q1
$591K Buy
14,679
+141
+1% +$5.65K 0.08% 57
2018
Q4
$602K Buy
14,538
+4,134
+40% +$172K 0.08% 60
2018
Q3
$435K Hold
10,404
0.07% 59
2018
Q2
$358K Sell
10,404
-11,594
-53% -$396K 0.06% 60
2018
Q1
$741K Sell
21,998
-275
-1% -$9.45K 0.12% 45
2017
Q4
$765K Buy
22,273
+157
+0.7% +$5.35K 0.12% 48
2017
Q3
$749K Sell
22,116
-6,160
-22% -$198K 0.12% 51
2017
Q2
$901K Sell
28,276
-7,940
-22% -$250K 0.13% 46
2017
Q1
$1.18M Buy
36,216
+3,171
+10% +$100K 0.17% 42
2016
Q4
$1.02M Buy
33,045
+1,581
+5% +$48.3K 0.15% 48
2016
Q3
$1.01M Sell
31,464
-99
-0.3% -$3.31K 0.15% 44
2016
Q2
$1.05M Buy
31,563
+7,726
+32% +$247K 0.17% 42
2016
Q1
$670K Buy
23,837
+527
+2% +$15.1K 0.11% 34
2015
Q4
$714K Hold
23,310
0.12% 32
2015
Q3
$695K Buy
23,310
+3,162
+16% +$101K 0.12% 32
2015
Q2
$641K Sell
20,148
-1,054
-5% -$34.4K 0.11% 35
2015
Q1
$700K Hold
21,202
0.12% 34
2014
Q4
$627K Hold
21,202
0.1% 40
2014
Q3
$595K Hold
21,202
0.1% 38
2014
Q2
$597K Sell
21,202
-475
-2% -$13.5K 0.1% 38
2014
Q1
$661K Hold
21,677
0.12% 36
2013
Q4
$630K Buy
21,677
+597
+3% +$17.4K 0.11% 34
2013
Q3
$575K Buy
21,080
+12,648
+150% +$344K 0.12% 34
2013
Q2
$224K Buy
+8,432
New +$233K 0.05% 47

Other funds holding PFE

BOK Financial Private Wealth's PFE Position: Q1 2026 in Review

BOK Financial Private Wealth reduced its Pfizer (PFE) stake by 0.84% in Q1 2026, selling an estimated $1.86K and leaving 8,275 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #171.

BOK Financial Private Wealth first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.44M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • BOK Financial Private Wealth held 8,275 shares of Pfizer worth $232K as of Q1 2026.
  • BOK Financial Private Wealth sold 70 Pfizer shares in Q1 2026, an estimated $1.86K.
  • Pfizer made up 0.01% of BOK Financial Private Wealth's portfolio in Q1 2026, its #171 holding.
  • BOK Financial Private Wealth first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • BOK Financial Private Wealth's Pfizer position peaked at $2.44M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on BOK Financial Private Wealth's 13F filing for Q1 2026, filed 12 May 2026.